Home/ Stocks/ AQST

Aquestive Therapeutics, Inc. Common Stock

AQST XNAS

$4.32 +0.05 (+1.18%) ▲ 15-min delayed

Open

$4.25

High

$4.36

Low

$4.25

Volume

1.89M

Market Cap

$536.91M

About Aquestive Therapeutics, Inc. Common Stock

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 147 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$44.55M	$-83,784,000	$-0.78
FY 2025	$44.55M	$-83,784,000	$-0.78
Q3 2025	$12.81M	$-15,446,000	$-0.14
Q2 2025	$10.00M	$-13,548,000	$-0.14

Related Market News

No specific coverage for AQST yet. Check out our latest market news or earnings calendar.

Get AQST Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Aquestive Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.